📋This is a sample report showing StockDossier's investigation format. Data is illustrative.
Start Investigating Real Stocks →Acme Acquisition Corp
Report Date: February 2026
Risk Assessment Gauge
Executive Summary
StockDossier identified 4 areas requiring further review in this investigation. Key findings include: sponsor cost basis significantly below current trading price with lock-up expiring in 47 days, limited public disclosure of CEO's prior Chapter 11 proceedings, and revenue pipeline consisting primarily of non-binding Letters of Intent. The bull case requires 3 high-confidence assumptions to materialize simultaneously.
7-Pillar Forensic Analysis
01Who Benefits If You Buy?
ELEVATED
Who Benefits If You Buy?
NOTE: Sponsor acquired 8,625,000 founder shares at $0.003/share. At current price of $14.20, the sponsor's position is worth $122.5M on paper. Lock-up expires in 47 days.
| Party | Shares | Cost Basis | Current Value | Lock-up |
|---|---|---|---|---|
| Sponsor (Acme Capital) | 8.625M | $0.003 | $122.5M | 47 days |
| PIPE Investors | 5.5M | $10.00 | $78.1M | 47 days |
| Retail (You) | Market | $14.20 | $14.20 | None |
Key Facts
- Sponsor's cost basis is 4,733× lower than retail price
- Lock-up expires August 12, 2026
- Historical data: 78% of SPAC sponsors sell within 30 days of lock-up expiry
- PIPE investors are also in profit and locked up for same period
Sources
02Narrative vs. Evidence
REVIEW NEEDED
Narrative vs. Evidence
Company states ‘$500M revenue pipeline’ in investor presentations. SEC filing shows this figure includes Letters of Intent, non-binding agreements. Confirmed contracted revenue per filings: $12M.
| Claim | Source | Verdict |
|---|---|---|
| “$500M pipeline” | Investor deck | REVIEW NEEDEDIncludes non-binding LOIs per filing |
| “Market leader in sector” | Press release | Not VerifiedNo cited methodology found |
| “Partnerships with Fortune 500” | Website | UNCONFIRMEDPilot agreements only; no revenue contracts found in filings |
| “$2B addressable market” | S-4 Filing | CONFIRMEDCited third-party research |
Sources
03Structural Legal Risks
HIGH
Structural Legal Risks
3 warrant tranches could dilute shareholders by up to 22%. Going-concern language present in most recent 10-Q.
04Management Track Record
HIGH
Management Track Record
Public records show CEO's previous company entered Chapter 11 proceedings in 2019. CFO was associated with a 2021 SEC regulatory matter (resolved). These details were found in public records but not referenced in investor-facing materials reviewed.
05Investor Cost Basis vs. Yours
ELEVATED
Investor Cost Basis vs. Yours
4 institutional investors entered at $10.00/share via PIPE. Current market price is $14.20, a 42% premium over institutional entry.
06Historical Analogues
HIGH
Historical Analogues
3 comparable SPACs showed an average return of -52% at 12 months. 1 of 3 avoided significant decline.
07Bull Case Stress Test
MEDIUM
Bull Case Stress Test
Bull case requires: 80% revenue growth (LOW confidence), successful product launch (MEDIUM), and management execution (LOW confidence given track record).
This Is What Every Investigation Looks Like
Real data. Verified sources. 60 seconds.
StockDossier runs this investigation on any stock, SPAC, or IPO you're considering.
Investigate Before You Invest